189 Epizód

  1. Treatment Options for Patients With Multiple Myeloma After First Relapse

    Közzétéve: 2021. 07. 14.

  2. Precision Medicine in Gynecologic Cancers: Expert Answers to Your Questions

    Közzétéve: 2021. 07. 12.

  3. Expert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas

    Közzétéve: 2021. 07. 12.

  4. Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer

    Közzétéve: 2021. 06. 30.

  5. Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions

    Közzétéve: 2021. 06. 29.

  6. Expert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer

    Közzétéve: 2021. 06. 24.

  7. Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

    Közzétéve: 2021. 06. 17.

  8. Experts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer

    Közzétéve: 2021. 05. 19.

  9. Congress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC

    Közzétéve: 2021. 05. 18.

  10. Immunotherapy for Advanced HCC: Case Series

    Közzétéve: 2021. 05. 17.

  11. Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany

    Közzétéve: 2021. 05. 13.

  12. Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond

    Közzétéve: 2021. 05. 04.

  13. Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer

    Közzétéve: 2021. 04. 28.

  14. Expert Answers to Questions on Contemporary Management of Multiple Myeloma

    Közzétéve: 2021. 04. 22.

  15. Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates

    Közzétéve: 2021. 04. 19.

  16. Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

    Közzétéve: 2021. 04. 15.

  17. Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer

    Közzétéve: 2021. 04. 06.

  18. Expert Answers to Questions on PARP Inhibition for Prostate Cancer

    Közzétéve: 2021. 04. 06.

  19. Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL

    Közzétéve: 2021. 03. 26.

  20. Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards

    Közzétéve: 2021. 03. 25.

7 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site